At close: December 13 at 4:00:02 PM EST
After hours: December 13 at 6:09:33 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Katharyn Field | Interim CEO & Executive Director | 111.97k | -- | 1983 |
Dr. Gurcharn Deol B.A., M.A., Ph.D. | Chief Financial Officer | 45.43k | -- | 1968 |
Akanda Corp.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Corporate Governance
Akanda Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
September 27, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
Related Tickers
PTPI Petros Pharmaceuticals, Inc.
0.3298
-5.83%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.6847
-6.44%
IMCC IM Cannabis Corp.
2.4700
+2.92%
BFRI Biofrontera Inc.
1.0600
0.00%
SXTC China SXT Pharmaceuticals, Inc.
0.3850
-4.54%
PRFX PainReform Ltd.
3.1100
+6.51%
SBFM Sunshine Biopharma, Inc.
2.7500
+1.48%
YCBD cbdMD, Inc.
0.3908
+0.21%
NTRR Neutra Corp.
0.0002
0.00%
OPTN OptiNose, Inc.
0.4710
-3.54%